Ardian launches sale of German pharma firm Riemser -sources

FRANKFURT, March 14 (Reuters) - Buyout group Ardian has launched the sale of German healthcare firm Riemser Pharma, which may fetch a valuation of more than 400 million euros ($495 million), people close to the matter said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.